Kevin J. Yeaman, President and CEO of Dolby Laboratories (DLB), has demonstrated a consistent pattern of selling activity in the company’s stock over recent months, with no recent purchases recorded. Since August 2025, Yeaman has executed multiple sales totaling approximately $17.78 million in aggregate value, with the largest single transaction occurring on December 9, 2025, when he sold shares worth $1.89 million. The sales have been frequent, with notable transactions on December 16–17, 2025, where he disposed of shares worth $1.45 million and $448,525, respectively, alongside smaller dispositions.
Yeaman’s trading history shows a clear divestment trend, with no buys reported in the same period. The transactions include a mix of open-market sales (coded "S") and dispositions tied to derivative securities (coded "M"), such as those on November 24, 2025, where he sold $2.46 million worth of shares while also exercising options. The absence of any recent acquisitions suggests a net reduction in his DLB holdings. While the filings do not indicate the reasons behind the sales, the data reflects a sustained sell-side bias over the past several months.
AI-assisted summary